The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Ulcerative Colitis
Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that can involve any aspect of the colon starting with mucosal inflammation in the rectum and extending proximally in a continuous fashion. Typical symptoms on presentation are bloody diarrhea, abdominal pain, fecal urgency, and tenesmus. In some patients, extraintestinal manifestations may predate the onset of gastrointestinal symptoms. A diagnosis of UC is made on the basis of presenting symptoms consistent with UC as well as endoscopic evidence showing continuous and diffuse colonic inflammation that starts in the rectum. Biopsies of the colon documenting chronic inflammation confirm the diagnosis of UC. Most cases are treated with pharmacological therapy to first induce remission and then to maintain a corticosteroid-free remission. There are multiple classes of drugs used to treat the disease. For mild to moderate UC, oral and rectal 5-aminosalycilates are typically used. In moderate to severe colitis, medication classes include thiopurines, biological agents targeting tumor necrosis factor and integrins, and the small-molecule Janus kinase inhibitors. However, in up to 15% of cases, patients in whom medical therapy fails or who have development of dysplasia secondary to their long-standing colitis will require surgical treatment. Finally, to minimize the complications of UC and adverse events from medications, a working collaboration between primary care physicians and gastroenterologists is necessary to make sure that vaccinations are optimized and that patients are screened for colon cancer, skin cancer, bone loss, depression, and other treatable and preventable complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,117
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Epidemiology and risk factors for IBD
Ananthakrishnan, A. N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.34 · Cited by 1,741
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., & Hanauer, S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,714
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Sandborn, W. J., van Assche, G., Reinisch, W., Colombel, J., D’Haens, G., Wolf, D. C., Kron, M., Tighe, M. B., Lazar, A., & Thakkar, R. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.032 · Cited by 1,269
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101
Panaccione, R., Ghosh, S., Middleton, S., Márquez, J. R., Scott, B. B., Flint, L., van Hoogstraten, H. J. F., Chen, A. C., Zheng, H., Danese, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 963
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J.-F., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.05.048 · Cited by 940
Extraintestinal Manifestations of Inflammatory Bowel Disease
Vavricka, S. R., Schoepfer, A., Scharl, M., Lakatos, P. L., Navarini, A., & Rogler, G. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000392 · Cited by 909
Reinisch, W., Sandborn, W. J., Hommes, D. W., D'Haens, G., Hanauer, S., Schreiber, S., Panaccione, R., Fedorak, R. N., Tighe, M. B., Huang, B., et al. (2011) · Gut · doi:10.1136/gut.2010.221127 · Cited by 892
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Colombel, J.-F., Sands, B. E., Rutgeerts, P., Sandborn, W., Danese, S., D'Haens, G., Panaccione, R., Loftus, E. V., Sankoh, S., Fox, I., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311079 · Cited by 806
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Smoking and Inflammatory Bowel Disease: A Meta-analysis
Mahid, S. S., Minor, K. S., Soto, R. E., Hornung, C. A., & Galandiuk, S. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.11.1462 · Cited by 774
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.06.010 · Cited by 727
Turner, D., Walsh, C. M., Steinhart, A. H., & Griffiths, A. M. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.033 · Cited by 659
Ananthakrishnan, A. N., Khalili, H., Konijeti, G. G., Higuchi, L. M., de Silva, P., Korzenik, J. R., Fuchs, C. S., Willett, W. C., Richter, J. M., & Chan, A. T. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.050 · Cited by 636
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Ford, A. C., Sandborn, W. J., Khan, K. J., Hanauer, S. B., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.73 · Cited by 604
Geographical variability and environmental risk factors in inflammatory bowel disease
Ng, S. C., Bernstein, C. N., Vatn, M. H., Lakatos, P. L., Loftus, E. V., Tysk, C., O'Morain, C., Moum, B., Colombel, J.-F., & on behalf of the Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD) (2013) · Gut · doi:10.1136/gutjnl-2012-303661 · Cited by 592
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Feuerstein, J. D., Nguyen, G. C., Kupfer, S. S., Falck-Ytter, Y., Singh, S., Gerson, L., Hirano, I., Nguyen, G. C., Rubenstein, J. H., Smalley, W. E., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.032 · Cited by 576
Self-citationMikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567
Farraye, F. A., Odze, R. D., Eaden, J., & Itzkowitz, S. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.037 · Cited by 532
Self-citationDecreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years
Jess, T., Simonsen, J., Jørgensen, K. T., Pedersen, B. V., Nielsen, N. M., & Frisch, M. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.016 · Cited by 532
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Long, M. D., Martin, C. F., Pipkin, C. A., Herfarth, H. H., Sandler, R. S., & Kappelman, M. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.004 · Cited by 526
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., & Tandon, R. K. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.016 · Cited by 513
Appendectomy and Protection against Ulcerative Colitis
Andersson, R. E., Olaison, G., Tysk, C., & Ekbom, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441104 · Cited by 503
Farraye, F. A., Odze, R. D., Eaden, J., & Itzkowitz, S. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.035 · Cited by 494
Self-citationTursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489
Shaw, S. Y., Blanchard, J. F., & Bernstein, C. N. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.398 · Cited by 483
Kotlyar, D. S., Osterman, M. T., Diamond, R. H., Porter, D., Blonski, W. C., Wasik, M., Sampat, S., Mendizabal, M., Lin, M. V., & Lichtenstein, G. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.016 · Cited by 477
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Self-citationAntibiotic Exposure and IBD Development Among Children: A Population-Based Cohort Study
Kronman, M. P., Zaoutis, T. E., Haynes, K., Feng, R., & Coffin, S. E. (2012) · Pediatrics · doi:10.1542/peds.2011-3886 · Cited by 445
Gradel, K. O., Nielsen, H. L., Schønheyder, H. C., Ejlertsen, T., Kristensen, B., & Nielsen, H. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.001 · Cited by 424
Laine, L., Kaltenbach, T., Barkun, A., McQuaid, K. R., Subramanian, V., Soetikno, R., East, J. E., Farraye, F. A., Feagan, B., Ioannidis, J., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.12.009 · Cited by 415
Self-citationBiomarkers of Inflammation in Inflammatory Bowel Disease
Sands, B. E. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.003 · Cited by 405
Menees, S. B., Powell, C., Kurlander, J., Goel, A., & Chey, W. D. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.6 · Cited by 391
Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
Black, A. J., McLeod, H. L., Capell, H. A., Powrie, R. H., Matowe, L. K., Pritchard, S. C., Collie-Duguid, E. S. R., & Reid, D. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00007 · Cited by 374
The role of endoscopy in inflammatory bowel disease
Shergill, A. K., Lightdale, J. R., Bruining, D. H., Acosta, R. D., Chandrasekhara, V., Chathadi, K. V., Decker, G. A., Early, D. S., Evans, J. A., Fanelli, R. D., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.10.030 · Cited by 362
Extraintestinal manifestations and complications in IBD
Ott, C., & Schölmerich, J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.117 · Cited by 351
Peeters, M., Joossens, S., Vermeire, S., Vlietinck, R., Bossuyt, X., & Rutgeerts, P. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03613.x · Cited by 344
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
Nielsen, O. H., & Ainsworth, M. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmct1209614 · Cited by 334
Patients with Inflammatory Bowel Disease Are at Risk for Vaccine-Preventable Illnesses
Melmed, G. Y., Ippoliti, A. F., Papadakis, K. A., Tran, T. T., Birt, J. L., Lee, S. K., Frenck, R. W., Targan, S. R., & Vasiliauskas, E. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00646.x · Cited by 326
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
Rutgeerts, P., Vermeire, S., & Van Assche, G. (2007) · Gut · doi:10.1136/gut.2005.088732 · Cited by 321
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
Alavi, A., French, L. E., Davis, M. D., Brassard, A., & Kirsner, R. S. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0251-7 · Cited by 321
Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
Ventham, N. T., Kennedy, N. A., Nimmo, E. R., & Satsangi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.050 · Cited by 320
Ben–Horin, S., Waterman, M., Kopylov, U., Yavzori, M., Picard, O., Fudim, E., Awadie, H., Weiss, B., & Chowers, Y. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.020 · Cited by 310
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Long, M. D., Herfarth, H. H., Pipkin, C. A., Porter, C. Q., Sandler, R. S., & Kappelman, M. D. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.11.024 · Cited by 306
The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis
Cornish, J. A., Tan, E., Simillis, C., Clark, S. K., Teare, J., & Tekkis, P. P. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02064.x · Cited by 297
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
Torres, J., Billioud, V., Sachar, D. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22839 · Cited by 296
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
Ford, A. C., Achkar, J.-P., Khan, K. J., Kane, S. V., Talley, N. J., Marshall, J. K., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.67 · Cited by 295
Vande Casteele, N., Herfarth, H., Katz, J., Falck-Ytter, Y., & Singh, S. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.031 · Cited by 295
Ankylosing spondylitis and bowel disease
Rudwaleit, M., & Baeten, D. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.03.010 · Cited by 275
Andersen, N. N., Pasternak, B., Basit, S., Andersson, M., Svanström, H., Caspersen, S., Munkholm, P., Hviid, A., & Jess, T. (2014) · JAMA · doi:10.1001/jama.2014.5613 · Cited by 273
Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis
Castaño‐Milla, C., Chaparro, M., & Gisbert, J. P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12651 · Cited by 268
Ananthakrishnan, A. N., Higuchi, L. M., Huang, E. S., Khalili, H., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-5-201203060-00007 · Cited by 262
Zholudev, A., Zurakowski, D., Young, W., Leichtner, A., & Bousvaros, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40369.x · Cited by 259
Lichtenstein, G. R., Abreu, M. T., Cohen, R., & Tremaine, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.047 · Cited by 252
Sandborn, W. J., Travis, S., Moro, L., Jones, R., Gautille, T., Bagin, R., Huang, M., Yeung, P., & Ballard, E. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.003 · Cited by 247
Karreman, M. C., Luime, J. J., Hazes, J. M. W., & Weel, A. E. A. M. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw199 · Cited by 247
Khan, K. J., Dubinsky, M. C., Ford, A. C., Ullman, T. A., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.64 · Cited by 246
Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977–2011
Moller, F. T., Andersen, V., Wohlfahrt, J., & Jess, T. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.50 · Cited by 246
TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS
Campieri, M., Lanfranchi, G. A., Bazzocchi, G., Franzin, G., Brignola, C., Battocchia, A., Sarti, F., Labo, G., & Dal Monte, P. R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90523-7 · Cited by 245
Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease
Kane, S., Khatibi, B., & Reddy, D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01582.x · Cited by 240
Singh, S., Fumery, M., Sandborn, W. J., & Murad, M. H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14422 · Cited by 235
Goodhand, J. R., Wahed, M., Mawdsley, J. E., Farmer, A. D., Aziz, Q., & Rampton, D. S. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22916 · Cited by 234
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
GISBERT, J. P., LINARES, P. M., MCNICHOLL, A. G., MATÉ, J., & GOMOLLÓN, F. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04023.x · Cited by 218
Narula, N., Marshall, J. K., Colombel, J.-F., Leontiadis, G. I., Williams, J. G., Muqtadir, Z., & Reinisch, W. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.7 · Cited by 204
Infectious Gastroenteritis and Risk of Developing Inflammatory Bowel Disease
Porter, C. K., Tribble, D. R., Aliaga, P. A., Halvorson, H. A., & Riddle, M. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.081 · Cited by 199
Probiotics for induction of remission in ulcerative colitis
Mallon, P. T., McKay, D., Kirk, S. J., & Gardiner, K. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005573.pub2 · Cited by 195
Danese, S., Fiorino, G., Peyrin-Biroulet, L., Lucenteforte, E., Virgili, G., Moja, L., & Bonovas, S. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2403 · Cited by 195
Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis
MARSHALL, J. K., & IRVINE, E. J. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00384.x · Cited by 194
Diet as a risk factor for the development of ulcerative colitis
Geerling, B. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00734-6 · Cited by 182
A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient
Wasan, S. K., Baker, S. E., Skolnik, P. R., & Farraye, F. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.733 · Cited by 179
Self-citationAriyaratnam, J., & Subramanian, V. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.451 · Cited by 165
Pouchitis: What Every Gastroenterologist Needs to Know
Shen, B. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.03.033 · Cited by 162
Isotretinoin use and the risk of inflammatory bowel disease: a case-control study
Crockett, S. D., Porter, C. Q., Martin, C. F., Sandler, R. S., & Kappelman, M. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.124 · Cited by 161
Vaccinating the inflammatory bowel disease patient: Deficiencies in gastroenterologists knowledge
Wasan, S. K., Coukos, J. A., & Farraye, F. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21667 · Cited by 160
Self-citationBiosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme
Razanskaite, V., Bettey, M., Downey, L., Wright, J., Callaghan, J., Rush, M., Whiteoak, S., Ker, S., Perry, K., Underhill, C., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw216 · Cited by 159
Ford, A. C., Khan, K. J., Achkar, J., & Moayyedi, P. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.410 · Cited by 158
Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts
Magro, F., Rodrigues, A., Vieira, A. I., Portela, F., Cremers, I., Cotter, J. B., Correia, L., Duarte, M. A., Tavares, M. L., Lago, P. M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21815 · Cited by 158
Risk factors for inflammatory bowel disease in the general population
Rodríguez, L. A. G., González‐Pérez, A., Johansson, S., & Wallander, M.-A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02564.x · Cited by 156
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
Timmer, A., McDonald, J. W., & MacDonald, J. K. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000478.pub2 · Cited by 153
Allegretti, J. R., Barnes, E. L., & Cameron, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000338 · Cited by 151
Ford, A. C., Moayyedi, P., & Hanauer, S. B. (2013) · BMJ · doi:10.1136/bmj.f432 · Cited by 150
Diet in the Aetiology of Ulcerative Colitis: A European Prospective Cohort Study
Hart, A. R., Luben, R., Olsen, A., Tjønneland, A. M., Linseisen, J., Nagel, G., Berglund, G., Lindgren, S. C., Grip, O., Key, T. J., et al. (2008) · Digestion · doi:10.1159/000121412 · Cited by 146
Hormone Therapy Increases Risk of Ulcerative Colitis but not Crohn's Disease
Khalili, H., Higuchi, L. M., Ananthakrishnan, A. N., Manson, J. E., Feskanich, D., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.096 · Cited by 142
Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
Sang, L.-X. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i15.1908 · Cited by 141
Cervical cancer screening: evidence behind the guidelines
Lees, B. F., Erickson, B. K., & Huh, W. K. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.10.147 · Cited by 130
Extraintestinal manifestations of inflammatory bowel disease
Williams, H. R. T., Walker, D. G., & Orchard, T. R. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0108-6 · Cited by 129
Axelrad, J. E., Bernheim, O. E., Colombel, J., Malerba, S., Ananthakrishnan, A. N., Yajnik, V., Hoffman, G., Agrawal, M., Lukin, D. J., Desai, A. P., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.037 · Cited by 121
Bernstein, C. N., Nugent, Z., Longobardi, T., & Blanchard, J. F. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.417 · Cited by 118
Walsh, A. J., Palmer, R. M., & Travis, S. P. L. (2014) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2014.03.005 · Cited by 117
Wasan, S. K., Calderwood, A. H., Long, M. D., Kappelman, M. D., Sandler, R. S., & Farraye, F. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437737.68841.87 · Cited by 110
Self-citationSetshedi, M., Epstein, D., Winter, T. A., Myer, L., Watermeyer, G., & Hift, R. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06865.x · Cited by 105
Ortizo, R. D., Lee, S. Y., Nguyen, E. T., Jamal, M. M., Bechtold, M. L., & Nguyen, D. L. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000915 · Cited by 102
Sandborn, W. J., Danese, S., D’Haens, G., Moro, L., Jones, R., Bagin, R. G., HUANG, M. L., Ballard, E. D., Masure, J. A., & Travis, S. P. L. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13076 · Cited by 89
Lack of association between cervical dysplasia and IBD: A large case–control study
Lees, C. W., Critchley, J., Chee, N., Beez, T., Gailer, R., Williams, A. R. W., Shand, A. G., Arnott, I. D., & Satsangi, J. J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20959 · Cited by 85
Thorlund, K., Druyts, E., Mills, E. J., Fedorak, R. N., & Marshall, J. K. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.01.010 · Cited by 85
Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Marshall, J. K., Thabane, M. E., Steinhart, A. H., Newman, J. R., Anand, A., & Irvine, E. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004118.pub2 · Cited by 79
Screening differences and risk of cervical cancer in inflammatory bowel disease
Hutfless, S. M., FIREMAN, B. H., Kane, S. V., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03766.x · Cited by 72
Schmitz, E. M. H., Boekema, P. J., Straathof, J.-W., van Renswouw, D. C., Brunsveld, L., Scharnhorst, V., van de Poll, M. E. C., Broeren, M. A. C., & Derijks, L. J. J. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14453 · Cited by 71
Probiotics for maintenance of remission in ulcerative colitis
Naidoo, K., Gordon, M. A., Fagbemi, A. A., Thomas, A. G., & Akobeng, A. K. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2010.186338.123 · Cited by 65
Feagan, B. G., & MacDonald, J. K. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23024 · Cited by 62
Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy
Papamichael, K., & Cheifetz, A. S. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.21 · Cited by 61
Isotretinoin and Risk of Inflammatory Bowel Disease: A French Nationwide Study
Racine, A., Cuerq, A., Bijon, A., Ricordeau, P., Weill, A., Allemand, H., Chosidow, O., Boutron‐Ruault, M., & Carbonnel, F. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.8 · Cited by 45
Indications and Options for Surgery in Ulcerative Colitis
Bohl, J. L., & Sobba, K. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2015.07.003 · Cited by 43
Alexakis, C., Saxena, S. K., Chhaya, V., Cecil, E. V., Ćurčin, V., & Pollok, R. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001031 · Cited by 42
Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease
Yadav, A., Foromera, J., Feuerstein, I., Falchuk, K. R., & Feuerstein, J. D. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001153 · Cited by 39
Self-citationUse of laboratory testing to guide 6-mercaptopurine/azathioprine therapy
Lichtenstein, G. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.061 · Cited by 38
Lester, R. A., Lu, Y., & Tung, J. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000730 · Cited by 25
Evaluation of bone mineral density in inflammatory bowel disease: current safety focus
Lichtenstein, G. R. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.11.003 · Cited by 21
Ulcerative Colitis from Genetics to Complications
Shennak, M. M. (2012) · InTech eBooks · doi:10.5772/2309 · Cited by 12
Cited by
Feagan, B. G., Danese, S., Loftus, E. V., Vermeire, S., Schreiber, S., Ritter, T., Fogel, R., Mehta, R., Nijhawan, S., Kempiński, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00666-8 · Cited by 462
Ma, C., Sedano, R., Almradi, A., Vande Casteele, N., Parker, C. E., Guizzetti, L., Schaeffer, D. F., Riddell, R. H., Pai, R. K., Battat, R., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.035 · Cited by 105
Liu, C., He, Y.-X., Zhang, J.-N., Yang, F., Wang, S.-Y., Hu, J.-L., & Yu, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2022.154490 · Cited by 27
Metadata
- Authors
- Feuerstein, J. D., Moss, A. C., & Farraye, F. A.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 94
- Issue
- 7
- Pages
- 1357-1373
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W4211018795
- Cited by
- 398
- References
- 125
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.